Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2301-2305

  Murugan, R Senthil ^a   Vinothini, G ^a   Hara, Y ^b   Nagini, S ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b Mitsui Norin Co Ltd ^*  (Japan)

Author keywords

Angiogenesis; Black tea polyphenols; Chemoprevention; Hepatocellular carcinoma; Histone deacetylation; Invasion

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; BLACK TEA EXTRACT; GELATINASE A; GELATINASE B; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MATRIX METALLOPROTEINASE; POLYPHENOL DERIVATIVE; POLYPHENON B; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER PREVENTION; CELL DIFFERENTIATION; CONTROLLED STUDY; DEACETYLATION; DIET; DISEASE MARKER; DRUG TARGETING; EPIGENETICS; INCIDENCE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANGIOGENIC PROTEINS; ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; HISTONE DEACETYLASES; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEA; TUMOR SUPPRESSOR PROTEINS;

EID: 67650886038     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR and Berry DP: Prognostic markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43: 979-992, 2007. (Pubitemid 46483030)
2. Hojilla CV, Mohammed FF and Khokha R: Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89: 1817-1821, 2003. (Pubitemid 37533251)
3. Roskoski R Jr: Vascular endothelial growth factor (VEGF) signaling in tumour progression. Crit Rev Oncol Haematol 62: 179-213, 2007. (Pubitemid 46679285)
4. Clark JC, Thomas DM, Choong PF and Dass CR: RECK- a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev 26: 675-683, 2007. (Pubitemid 350115122)
5. Chang HC, Liu LT and Hung WC: Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Cell Signal 16: 675-699, 2004.
6. Khan N, Afaq F and Mukhtar H: Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Sign 10: 1-36, 2008.
7. Khan N and Mukhtar H: Tea polyphenols for health promotion. Life Sci 81: 519-533, 2007.
8. Vidjaya Letchoumy P, Chandra Mohan KVP, Prathiba D, Hara Y and Nagini S: Comparative evaluation of antiproliferative, antiangiogenic and apoptosis inducing potential of black tea polyphenols in the hamster buccal pouch carcinogenesis model. J Carcinog 6: 19, 2007. (Pubitemid 351188977)
9. Kumaraguruparan R, Seshagiri PB, Hara Y and Nagini S. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: modulation of xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation, apoptosis and angiogenesis. Mol Carcinog 46: 797-806, 2007. (Pubitemid 47438730)
10. Senthil Murugan R, Chandra Mohan KVP, Uchida K, Hara Y, Prathiba D and Nagini S: Modulatory effects of black tea polyphenols on oxidant-antioxidant profile and expression of proliferation, apoptosis, and angiogenesis associated proteins in the rat forestomach carcinogenesis model. J Gastroenterol 42: 352-361, 2007.
11. Senthil Murugan R, Uchida K, Hara Y and Nagini S: Black tea polyphenols modulate xenobiotic-metabolising enzymes, oxidative stress and adduct formation in a rat hepatocarcinogenesis model. Free Radic Res 42: 873-884, 2008.
12. Tang ZY: Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 7: 445-454, 2001.
13. Liu Z, Yan L, Xiang T, Jiang L and Yang B: Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20: 249-254, 2003.
14. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM and Shibuya M: MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300, 2002. (Pubitemid 41043963)
15. Yoo YG, Na TY, Seo HW, Seong JK, Park CK, Shin YK and Lee MO: Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 27: 3405-3413, 2008. (Pubitemid 351769313)
16. Siddiqui IA, Zaman N and Aziz MH: Inhibition of CWR22Rv1 tumour growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis 27: 833-839, 2008.
17. Sazuka M, Imazawa H, Shoji Y, Mita T, Hara Y and Isemura M: Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins. Biosci Biotechnol Biochem 61: 1504-1506, 1997. (Pubitemid 127472971)
18. Lin SK, Shun CT, Kok SH, Wang CC, Hsiao TY and Liu CM: Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis. Arch Otolaryngol Head Neck Surg 134: 522-527, 2008. (Pubitemid 351724384)
19. Ho Y-C, Yang S-F, Peng X-Y, Chou M-Y and Chang Y-C: Epigallocatechin-3- gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J Oral Pathol Med 36: 588-593, 2007. (Pubitemid 47609810)
20. Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y and Isemura M: Effects of tea polyphenol on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J Agric Food Chem 47: 2350-2354, 1999. (Pubitemid 29325123)
21. Overall CM and Kleifeld O: Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nature Rev Cancer 6: 227-239, 2006.
22. Duda DG, Batchelor TT, Willett CG and Jain RK: VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. Trends Mol Med 13: 223-230, 2007. (Pubitemid 46836870)
23. Mottet D and Castronovo V: Histone deacetylases: target enzyme for cancer therapy. Clin Exp Metastasis 25: 183-189, 2008.